
❄ Compounded semaglutide is only available to patients who meet appropriate medical criteria and for whom a licensed healthcare provider has determined there is a clinical need that cannot be mt by an FDA-approved drug. Eligibility must be established through a proper medical evaluation, which may be conducted via telehealth where permitted by law.
❄ Disclaimer
Product Description:
Semaglutide is a glucagon-like peptide (GLP-1). This compounded GLP-1 is a custom formulation designed to mimic the effects of naturally occurring GLP-1, a hormone involved in regulating blood sugar levels and appetite. This medication is often used in the management of type 2 diabetes and weight loss. It works by stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying, and promoting satiety. Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control. The greatest weight loss benefits were observed when taken in combination with lifestyle changes such as improved diet and exercise.